BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20332694)

  • 21. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eyelid metastasis from breast cancer showing marked response to chemotherapy.
    Zhang GJ; Adachi I; Yin DF; Narabayashi M; Tokue Y; Watanabe T; Kaneko A; Tsuda H; Abe K
    Jpn J Clin Oncol; 1995 Feb; 25(1):10-5. PubMed ID: 7877258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of long-term survival of liver metastasis of breast cancer successfully treated with chemotherapy and endocrine therapy].
    Shiba E; Koyama H; Sasaki Y; Iwanaga T; Terasawa T; Wada A
    Gan No Rinsho; 1985 Sep; 31(11):1439-44. PubMed ID: 3934423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
    Tamada S; Sagara Y; Baba S; Sagara Y; Yotsumoto D; Matsukata A; Andou M; Sagara Y; Rai Y
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):635-7. PubMed ID: 21498994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
    Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
    Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of breast cancer patient of CAF (cyclophosphamide, adriamycin, 5-fluorouracil) resistant lung metastasis with remarkable response to reverse drug-resistance by toremifene].
    Kusama M; Kaise H; Nakayama S; Ohta D; Aoki T; Koyanagi Y
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1171-5. PubMed ID: 10431584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.
    Bellon JR; Shulman LN; Come SE; Li X; Gelman RS; Silver BJ; Harris JR; Recht A
    Cancer; 2004 Apr; 100(7):1358-64. PubMed ID: 15042668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide, methotrexate and fluorouracil (CMF) versus hormonal ablation with leuprorelin acetate as adjuvant treatment of node-positive, premenopausal breast cancer patients: preliminary results of the TABLE-study (Takeda Adjuvant Breast cancer study with Leuprorelin Acetate).
    Schmid P; Untch M; Wallwiener D; Kossé V; Bondar G; Vassiljev L; Tarutinov V; Kienle E; Lüftner D; Possinger K;
    Anticancer Res; 2002; 22(4):2325-32. PubMed ID: 12174922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of hepatic arterial infusion chemotherapy for multiple liver metastasis from breast cancer].
    Hara S; Hashizume S; Itoyanagi N; Ayabe H; Tagawa Y; Tsuji H; Oka T; Yamamoto S; Shinguu H; Tou K; Tooyama H; Yamazumi K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1809-12. PubMed ID: 9382538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.
    Coskun U; Gunel N; Onuk E; Yilmaz E; Bayram O; Yamac D; Cihan A; Ucan B; Yildirim Y; Celenkoglu G; Ozkan S
    Neoplasma; 2003; 50(3):210-6. PubMed ID: 12937855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experience of intra-arterial chemotherapy for liver metastases of breast cancer patients].
    Tokura H; Ikeda T; Masamura S; Matsui A; Hojo T; Kawaguchi M; Takayama S; Mitsui Y; Miyabe R; Kitajima M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1780-2. PubMed ID: 11708033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
    Izumi M; Iino Y; Yokoe T; Inoue T; Yamada T; Kobayashi I; Andoh T; Yokota T; Iijima T; Morishita Y
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):265-8. PubMed ID: 8311500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group.
    Knoop AS; Knudsen H; Balslev E; Rasmussen BB; Overgaard J; Nielsen KV; Schonau A; Gunnarsdóttir K; Olsen KE; Mouridsen H; Ejlertsen B;
    J Clin Oncol; 2005 Oct; 23(30):7483-90. PubMed ID: 16234514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
    Taucher S; Steger GG; Jakesz R; Tausch C; Wette V; Schippinger W; Kwasny W; Reiner G; Greil R; Dubsky P; Poestlberger S; Tschmelitsch J; Samonigg H; Gnant M;
    Breast Cancer Res Treat; 2008 Nov; 112(2):309-16. PubMed ID: 18080748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
    de Haes H; Olschewski M; Kaufmann M; Schumacher M; Jonat W; Sauerbrei W;
    J Clin Oncol; 2003 Dec; 21(24):4510-6. PubMed ID: 14610048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of breast cancer postoperative metastases to the liver obtained cCR].
    Enomoto K; Sakurai K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2075-7. PubMed ID: 22202288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of recurrent breast cancer with liver metastases showing good response to combination therapy with S-1 plus trastuzumab].
    Ishida K
    Gan To Kagaku Ryoho; 2013 Oct; 40(10):1385-7. PubMed ID: 24196076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
    Kokufu I; Taniguchi H; Kim YH; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1335-8. PubMed ID: 10478188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.